[go: up one dir, main page]

WO2022245849A3 - Compléments pour supporter une fonction métabolique - Google Patents

Compléments pour supporter une fonction métabolique Download PDF

Info

Publication number
WO2022245849A3
WO2022245849A3 PCT/US2022/029662 US2022029662W WO2022245849A3 WO 2022245849 A3 WO2022245849 A3 WO 2022245849A3 US 2022029662 W US2022029662 W US 2022029662W WO 2022245849 A3 WO2022245849 A3 WO 2022245849A3
Authority
WO
WIPO (PCT)
Prior art keywords
metabolic function
supplements
supporting
supporting metabolic
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2022/029662
Other languages
English (en)
Other versions
WO2022245849A2 (fr
Inventor
Guruduth S. Banavar
Hilary KEISER
Joshua Grant ANTOINE
Janelle CONNELL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viome Life Sciences Inc
Original Assignee
Viome Life Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viome Life Sciences Inc filed Critical Viome Life Sciences Inc
Publication of WO2022245849A2 publication Critical patent/WO2022245849A2/fr
Publication of WO2022245849A3 publication Critical patent/WO2022245849A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/75—Rutaceae (Rue family)
    • A61K36/752—Citrus, e.g. lime, orange or lemon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions qui supportent une fonction métabolique. Les compositions comprennent un ou plusieurs parmi la berbérine et le mûrier blanc ; le chrome ; et l'un ou les deux parmi le postbiotique B. lactis ou B. longum BL-05. L'invention concerne aussi les flavonoïdes d'agrumes ; le butyrate ; l'écorce de quebracho ; l'extrait de racine de gingembre ; l'extrait de fleur de camomille ; et la curcumine.
PCT/US2022/029662 2021-05-17 2022-05-17 Compléments pour supporter une fonction métabolique Ceased WO2022245849A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202163189566P 2021-05-17 2021-05-17
US63/189,566 2021-05-17

Publications (2)

Publication Number Publication Date
WO2022245849A2 WO2022245849A2 (fr) 2022-11-24
WO2022245849A3 true WO2022245849A3 (fr) 2022-12-29

Family

ID=84140979

Family Applications (3)

Application Number Title Priority Date Filing Date
PCT/US2022/029662 Ceased WO2022245849A2 (fr) 2021-05-17 2022-05-17 Compléments pour supporter une fonction métabolique
PCT/US2022/029711 Ceased WO2022245882A1 (fr) 2021-05-17 2022-05-17 Suppléments pour favoriser la santé gastro-intestinale
PCT/US2022/029702 Ceased WO2022245875A1 (fr) 2021-05-17 2022-05-17 Compléments pour la prise en charge de la santé mentale

Family Applications After (2)

Application Number Title Priority Date Filing Date
PCT/US2022/029711 Ceased WO2022245882A1 (fr) 2021-05-17 2022-05-17 Suppléments pour favoriser la santé gastro-intestinale
PCT/US2022/029702 Ceased WO2022245875A1 (fr) 2021-05-17 2022-05-17 Compléments pour la prise en charge de la santé mentale

Country Status (1)

Country Link
WO (3) WO2022245849A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025008468A1 (fr) * 2023-07-04 2025-01-09 Biopolis, S.L. Utilisations pour la santé d'une souche bifidobacterium animalis subsp lactis cect 8145 et d'un lta associé
IT202300025281A1 (it) * 2023-11-28 2025-05-28 N I Pharma Soc A Responsabilita Limitata Alimento per la gestione dietetica delle colopatie

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101485748A (zh) * 2009-02-20 2009-07-22 西南大学 一种治疗糖尿病的植物提取物复方制剂
US9539247B2 (en) * 2014-11-28 2017-01-10 AKADEMY PHARMA S.r.L. Nutraceutical composition for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia
WO2017008909A1 (fr) * 2015-07-16 2017-01-19 Rottapharm S. P. A. Formulation orale comprenant de la berbérine et extrait de morue alba

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291533B1 (en) * 1999-12-22 2001-09-18 Vitamerica, Inc. Dietary supplements for each specific blood type
US20030206978A1 (en) * 2001-11-29 2003-11-06 Bob Sherwood Agglomerated particles including an active agent coprocessed with silicified microcrystalline cellulose
US8257694B2 (en) * 2009-05-14 2012-09-04 Product Partners, Llc Nutritional compositions for reducing oxidative damage
CN103491951A (zh) * 2011-02-28 2014-01-01 赫洛罗斯技术股份有限公司 用于口吸收的可咀嚼媒介物
US20190117555A1 (en) * 2016-03-11 2019-04-25 Harmonic Pharma Sublingual compositions comprising natural extracts and uses thereof
US11534468B2 (en) * 2017-12-06 2022-12-27 Lac2biome S.r.l. Composition based on probiotics and uses thereof
US10517322B1 (en) * 2018-03-19 2019-12-31 Life Kitchen, LLC Dietary supplement formulations for promoting sleep
WO2020205676A1 (fr) * 2019-03-29 2020-10-08 V Rush Vapes LLC Composition de suppléments pour athlétisme et entraînement physique, procédé de production et procédé d'administration pulmonaire de celle-ci
US20220347257A1 (en) * 2019-07-02 2022-11-03 Microsintesis Inc. Quorum-sensing inhibitors and/or postbiotic metabolites and related methods

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101485748A (zh) * 2009-02-20 2009-07-22 西南大学 一种治疗糖尿病的植物提取物复方制剂
US9539247B2 (en) * 2014-11-28 2017-01-10 AKADEMY PHARMA S.r.L. Nutraceutical composition for the treatment of excess weight and moderate hypercholesterolemia/dysglycemia
WO2017008909A1 (fr) * 2015-07-16 2017-01-19 Rottapharm S. P. A. Formulation orale comprenant de la berbérine et extrait de morue alba

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
KOPPEN LAURA M., WHITAKER ANDREA, ROSENE AUDREY, BECKETT ROBERT D.: "Efficacy of Berberine Alone and in Combination for the Treatment of Hyperlipidemia: A Systematic Review", JOURNAL OF EVIDENCE-BASED COMPLEMENTARY & ALTERNATIVE MEDICINE, vol. 22, no. 4, 1 October 2017 (2017-10-01), pages 956 - 968, XP093021000, ISSN: 2156-5872, DOI: 10.1177/2156587216687695 *

Also Published As

Publication number Publication date
WO2022245849A2 (fr) 2022-11-24
WO2022245882A1 (fr) 2022-11-24
WO2022245875A1 (fr) 2022-11-24

Similar Documents

Publication Publication Date Title
Lee et al. Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo
Hou et al. Anthocyanidins inhibit cyclooxygenase-2 expression in LPS-evoked macrophages: structure–activity relationship and molecular mechanisms involved
WO2022245849A3 (fr) Compléments pour supporter une fonction métabolique
AR048181A1 (es) Composicion de ingredientes funcionales
WO2012033634A3 (fr) Formulations topiques de soin de la peau contenant des extraits de plantes
WO2006075330A3 (fr) Procedes et compositions pharmaceutiques utilisees pour le traitement du psoriasis
Herrera Herrera et al. Susceptibility of Porphyromonas gingivalis and Streptococcus mutans to Antibacterial Effect from Mammea americana
WO2015061798A3 (fr) Compositions et procédés faisant appel à des organismes de type levures et à des extraits lipidiques de ceux-ci
BR112023026246A2 (pt) Modificação de pacotes mensageiros de planta
Lianza et al. Screening of ninety herbal products of commercial interest as potential ingredients for phytocosmetics
Ayo et al. Phytochemical screening and antimicrobial activity of three plants used in traditional medicine in Northern Nigeria
CL2008001685A1 (es) Extracto de piel de almendra antioxidante con un contenido fenolico mayor 5% que contiene procianidinas, propelargonidinas y prodelfinidinas; procedimiento de preparacion del extracto: preparacion del material vegetal que contenga la piel, extraccion de la piel con disolvente organicos, secado; usos.
EP4132988A4 (fr) Compositions de citrate dopées au xylitol et leurs utilisations
WO2006078699A3 (fr) Compositions pour soins buccaux derivees de la famille labiatae
WO2010147814A3 (fr) Combinaisons d'extraits d'herbe ayant un effet antioxydant synergique et procédés apparentés à celles-ci
CA3011018A1 (fr) Derive de noreugenine glycoside
BR112021001672A8 (pt) Citratos peridratados, seus usos, composição que compreende um citrato peridratado e método de preparação de uma composição
ES2422423T3 (es) Usos cosméticos y farmacéuticos de un extracto de las semillas de Buchholzia coriacea
WO2019209228A3 (fr) Compositions orales solides comprenant du miel séché et des extraits d'herbes
EP4595777A3 (fr) Compositions de complément à base de plantes
EP4401751A4 (fr) Compositions de thiostrepton et leur préparation
WO2011038472A8 (fr) Extrait végétal normalisé, procédé de préparation d'extrait de plantes du genre sclerolobium, composition cosmétique, composition pharmaceutique et utilisation dudit extrait
Sun et al. Effect of ultra-high pressure pretreatment on antioxidant capacity and cytoprotective activities against oxidative damage on HepG2 cells of peel of Passiflora edulis sims.
Lee Anti-oxidative and anti-proliferative effect of 70% ethanol extracts from green pepper (Capsicum annuum L. cv. DangZo)
IT201900025063A1 (it) Composizioni gastroresistenti comprendi inositolo e/o estratto di gymnema sylvestre, loro composizioni farmaceutiche e nutraceutiche e loro uso

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22805335

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22805335

Country of ref document: EP

Kind code of ref document: A2